Observational studyBMC endocrine disorders2026
Thyroid dysfunction and its association with micronutrients, lipids, and inflammation: an analytical case-control study.
Observational study in BMC endocrine disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Thyroid markers in early to mid-pregnancy and risk of gestational diabetes: a longitudinal retrospective cohort study.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBiochemical, inflammatory, and immunological markers may provide insight into systemic alterations in individuals with or without thyroid dysfunction.
aimThis study compared a comprehensive biomarker profile between adults without thyroid disease and those with thyroid dysfunction, and examined gender differences, correlations, and predictive markers.
methodsIn this case-control study, 120 adults without thyroid disease (cases) and 120 adults with thyroid dysfunction (controls) were enrolled. Demographics, anthropometry, and biochemical parameters-including thyroid hormones, micronutrients, lipid profiles, inflammatory markers, and Epstein-Barr virus PCR-were assessed. Between-group differences were analyzed using the Mann-Whitney U test and the χ² test. Spearman's rho was used to determine correlations, and multivariable linear regression was used to identify predictors of group status.
resultsCases and controls were similar in age (60 ± 12 vs. 60 ± 10.5 years) and body mass index (BMI) (24.85 ± 3.69 vs. 25.58 ± 3.39 kg/m²). Compared with controls, cases had significantly lower zinc (97.98 vs. 143.03 µg/dL), vitamin D₃ (88.24 vs. 152.76 nmol/L), and HDL (88.75 vs. 152.25 mg/dL), but higher serum cholesterol (159.56 vs. 81.44 mg/dL), triglycerides (TG) (171.08 vs. 69.92 mg/dL), LDL (136.06 vs. 104.94 mg/dL), and CRP (140.05 vs. 100.95 mg/L) (all p < 0.001). In controls, TSH correlated positively with the Urea Breath Test (UBT) (rho = 0.334) and negatively with LDL (rho=-0.255). In cases, T3 showed a strong correlation with UBT (rho = 0.625) and a moderate correlation with PCR-EBV (rho = 0.417), while TSH correlated with UBT (rho = 0.434) and CRP (rho = 0.264). Regression analysis identified serum TG (β = 76.806, R²=0.462) and cholesterol (β = 64.834, R²=0.337) as the strongest predictors of case-control status.
conclusionAdults without thyroid disease exhibit distinct biochemical and inflammatory profiles compared with those with thyroid dysfunction, highlighting lipid, micronutrient, and inflammatory markers as potential targets for risk stratification and clinical monitoring. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.